Trial Profile
Efficacy of bosentan in patients with idiopathic pulmonary arterial hypertension (IPAH).
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 31 Dec 2015
Price :
$35
*
At a glance
- Drugs Bosentan (Primary)
- Indications Pulmonary arterial hypertension
- Focus Therapeutic Use
- 31 Dec 2015 New trial record